SeaSpine Holdings Corporation, headquartered in the United States, is a prominent player in the spinal surgery industry, specialising in innovative solutions for spinal fusion and orthopaedic procedures. Founded in 2015, the company has rapidly established itself as a leader in the development of advanced surgical technologies and biologics, focusing on enhancing patient outcomes. With a diverse portfolio that includes spinal implants, surgical instruments, and regenerative biologics, SeaSpine distinguishes itself through its commitment to research and development, ensuring that its products meet the evolving needs of healthcare professionals. The company operates primarily in North America, with a growing presence in international markets. Recognised for its cutting-edge technologies and strong market position, SeaSpine continues to achieve significant milestones, contributing to advancements in spinal surgery and improving the quality of life for patients worldwide.
How does SeaSpine Holdings Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SeaSpine Holdings Corporation's score of 25 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SeaSpine Holdings Corporation, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Orthofix Medical Inc., which may influence its climate commitments and emissions reporting. As of now, SeaSpine has not established any documented reduction targets or climate pledges. The absence of specific emissions data suggests that the company may be in the early stages of developing its sustainability strategy or reporting framework. Given its relationship with Orthofix Medical Inc., any potential emissions data or climate initiatives may be inherited from this parent company. However, no specific figures or targets have been disclosed in relation to this cascade. In the broader context of the medical device industry, companies are increasingly recognising the importance of sustainability and are expected to adopt more robust climate commitments in the future. SeaSpine's current lack of emissions data and reduction initiatives highlights an opportunity for the company to enhance its environmental responsibility and align with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 871,000 | 000,000 |
| Scope 2 | 2,118,000 | 0,000,000 |
| Scope 3 | 68,000 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SeaSpine Holdings Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.